EXMceuticals Closes 2nd Tranche of Private Placement
NOT FOR RELEASE IN THE UNITED STATES OR TO U.S. NEWS WIRE SERVICES
April 16, 2019, Vancouver, British Columbia – EXMceuticals Inc. (CSE: EXM) (the “Company”) is pleased to announce that it has completed the second tranche of its non-brokered private placement (the “Offering”). Further to the news release dated March 14, 2019, the Company raised additional gross proceeds of $2,506,820 by way of private placement of 1,856,904 common shares (the “Shares”) at a price of $1.35 per Share, in the second tranche. The Company has raised aggregate gross proceeds of $3,518,538 from the first and second tranche closings.
All Shares sold in connection with the Offering are subject to a 4-month hold period expiring on August 18, 2019 as prescribed by the Canadian Securities Exchange and applicable securities laws. The proceeds from the Offering will be used for general working capital. In connection with the second tranche of the Offering, the Company agreed to pay aggregate finders’ fees of $142,969 in cash and issue an aggregate of 105,903 finders’ warrants (the “Finders Warrants”). Each Finders Warrant is exercisable into one common share in the capital of the Company at a price of $1.35 for a period of 18 months from closing of the Offering.
ON BEHALF OF THE BOARD OF DIRECTORS OF EXMCEUTICALS INC.
Michel Passebon, Chief Executive Officer and Director
For further information contact:
John Anderson, Chairman
Telephone: +1 403-870-1562
Telephone: +1 604 897 0132
The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.
Aktuelle Pressemeldungen dieses Unternehmens direkt in Ihr Postfach:
Mitteilung übermittelt durch IRW-Press.com. Für den Inhalt ist der Aussender verantwortlich.
Kostenloser Abdruck mit Quellenangabe erlaubt.